Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2012: Clinical Research  

Optimizing HgA1C and glucose monitoring frequency in patients with Type 2 diabetes

Juanita F. Bridges ABCDEFG , Daniel Brignac ADE , Sequria Thomas AD , Carmen Kent AD , Marilyn Ogbuli AD , Jeanne Draper D , Helen Rasumssen AD , Akane Daniels AD , Darlene Cook AD , Caroline Chartier AD , Lauren Brewer CD , Hani Mesak CD

DOI: 10.12659/MSM.883594

Med Sci Monit 2012; 18(12): CR693-697

0 Comments

Background

Individuals with diabetes do not realize the consequences of poorly controlled blood sugars until injury occur [1–4]. The Diabetes Control and Complications Trial (DCCT) showed that glycemic control delays the onset of microvascular and macrovascular complications [5]. Glucose monitoring allows individuals with diabetes the opportunity to establish targets they should achieve for glucose control [6,7]. In the United Kingdom Prospective Diabetes Study (UKPDS), patients with new onset type 2 diabetes showed benefits in achieving glucose control evidenced by reductions in microvascular and neuropathic complications [8]. Self monitoring glucose is an important tool used to provide education and self management instructions to achieve optimal glucose levels [9]. There are multiple barriers that exist between the transfer and application of theoretical knowledge to patients [10,11]. For example, recent studies have focused on specific aspects of diabetes education in patients with cognitive impairment to a specific education program for insulin management and suggest that education should focus on specific needs expressed by the older population [12–15]. Diabetes education is a key aspect in diabetes management and is a collaborative process allowing the patient with diabetes to receive knowledge and skills needed to change behavior and successfully manage the disease [16,17]. A formal diabetes education program is a comprehensive program that is designed to enrich a patient’s knowledge in diabetes management skills to problem solve unanticipated situations of hyperglycemia and hypoglycemia and sick-days, reduce risks associated with diabetes, and help with the healthy coping of day to day challenges of living with the disease [18–20]. Goals of diabetes therapy are to achieve optimal glucose and lipid values, improve quality of life and reduce health care costs [21].

Material and Methods

It is a cross sectional study done after an institutional review board approval. The study looked at 67 subjects with type 2 diabetes treated with diet alone, 350 subjects treated with tablets, 155 subjects treated with insulin, and 228 subjects treated with both tablets and insulin. Subjects had an average of 6 co-morbidities and 9 prescription medications respectively. Subjects were followed in a Shared Medical Appointment (SMA) as part of a Diabetes Self Management Education (DSME) program in the primary care setting in three intervals over 28 months. Exclusion criteria include subjects with limited physical abilities who were unable to participate in group diabetes self management education. Participants may have had prior individualized diabetes & carbohydrate counting education [22,23]. The study utilized the facility’s Computerized Patient Record System (CPRS) upon entry and again at the third visit to collect hemoglobin HgA1C and frequency of reported glucose tests. Specific instructions for home glucose monitoring are given at routine office visits and at DSME visits. All subjects with a diagnosis of diabetes are given precise instructions to monitor glucose and interpret results. Formal DSME is provided by interdisciplinary staff instructors and re-enforced in three group visits before discharge to the Primary Physician. The curriculum content used is structured according to the National Standards for Diabetes Self Management Education, tailored to match individual’s needs and adapted as necessary for age, type of diabetes, cultural influences, health literacy and other co-morbidities. SPSS version 19 is used to regress the dependent variable, drop in hemoglobin HgA1C level, on the independent categorical variables through linear regression.

Results

Using the enter method of linear regression the full model including medication type, medication level, gender, and family support indicates overall model significance (p<.01) and R2=.056. The medication levels, insulin and tablet plus insulin produce positive significant coefficients (p<.05). The positive coefficient indicates that both variables produce a mean difference value greater than that of no medication used, lowering the HgA1C level by a larger amount. Under the glucose monitoring category, monitoring 4–7 times per week produces a positive significant coefficient (p<.05). None of the other monitoring levels were significant. Gender and family support were found to be insignificant in the analysis. A second model was estimated using the enter method of linear regression without gender and family support indicating overall model significance (p<.01) and R2=.054, finding the same conclusions as previously stated. A third model using the enter method of linear regression was used to assess the significance of medication level. The overall model is significant (p<.01) and R2=.050. The combined model finds significance (p<.05) for the computed variable combining insulin and tablet plus insulin. Further analysis comparing the combined model to the reduced model indicates that taking both the tablet and insulin is more effective at lowering HgA1C levels than taking insulin alone at the 0.10 level of significance. As a matter of fact, the raw data indicates that the percentage lowering of HgA1C of tablet plus insulin is 15.64% as the mean HgA1C at the first visit was 9.35 compared to 7.89 at the later visit whereas the percentage lowering of HgA1C for insulin was 12.24% as the mean HgA1C at the first visit was 9.37 compared to 8.23 at the later visit.

Discussion

We tested the hypothesis that achieving optimal HgA1C results is directly correlated to the frequency of self monitoring in subjects with type 2 diabetes. We found that at the time of diagnosis, many patients with type 2 diabetes were motivated to test frequently as was prescribed, and problem solve towards successful outcome [24–26]. The National Standards for Diabetes Self Management Education guide was used to formulate the education and match individual’s needs, and adapt as necessary for age, the type of diabetes, cultural influences, health literacy and other co-morbidities. Utilization of print, audio, and models to deliver the education was also used. However, after 5mos, many subjects were less inclined to test glucoses, report results, and maintain focus. When this behavior was observed, our intervention was to engage each subject individually by offering 1:1 appointments with DSME staff to discuss obstacles [8,11]. We found that coaching subjects towards glucose monitoring and problem solving lead to preventable hospitalizations. Contacting telephonically was highly accepted and successfully integrated into treatment plan. Furthermore, the present study has shown that empowering the subject with diabetes to practice self care management is imperative to reaching HgA1C targets. However, the subject with the diagnosis, ultimately decides the glucose monitoring frequency needed to successfully achieve glucose targets.

Conclusions

Tables 1–3 represent each of the estimated models, the un-standardized coefficients, corresponding significance levels, and the ninety five percent confidence intervals. Thus, the following conclusions were made: (1) frequency of self monitoring should be based on individualized goals and willingness to participate, as seen in this study the best frequency for glucose monitoring is between 4 and 7 times per week; (2) both insulin alone and tablet plus insulin levels of medication are effective at lowering HgA1C levels in patients, however, using the tablet and insulin combined produced lower HgA1C levels than using insulin alone; (3) family support and gender have no effect on lowering HGA1C levels in patients. (Descriptive statistics of the analyzed data are depicted in Table 4).

References

1. Sprague MA, Shultz JA, Branen LJ, Understanding patient experiences with goal setting for diabetes self-management after diabetes education: Fam Community Health, 2006; 29; 245-55, pmid: 16980800

2. Deakin TA, Cade JE, Williams R, Greenwood DC, Structured patient education: the diabetes x-pert programme makes a difference: Journal Compilation. Diabetes UK. Diabet Med, 2006; 23; 944-54

3. Leichter SB, Economic considerations in the application of clinical standards and requirements in diabetes care: Clinical Diabetes, 2000; 18; 1-5

4. ADA, Economic costs of diabetes in the U.S. in 2007: Diabetes Care, 2008; 31; 1-20

5. The Diabetes Control and Complications Trial Research Group: N England J Med, 1993; 329; 977-86, pmid: 8366922

6. Schachinger H, Hegar K, Hermanns N, Randomized controlled clinical trial of blood glucose awareness training (BGAT III) in Switzerland and Germany: J Behav Med, 2005; 28; 587-94, pmid: 16222412

7. Feathers J, Kieffer EC, Palmisano G, The development, implementation, and process evaluation of the REACH Detroit Partnership’s diabetes lifestyle intervention (REPORT), 2007; 33; 509

8. UK Prospective Diabetes Study: Lancet, 1998; 352; 837-65, pmid: 9742976

9. Harris MI, Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes: Diabetes Care, 2001; 24; 979-82, pmid: 11375356

10. Trento M, Passera P, Tomalino M, Group visits improve metabolic control in type 2 diabetes a two year follow up: Diabetes Care, 2001; 24; 995-1000, pmid: 11375359

11. Norris S, Engelgau M, Narayan KM, Effectiveness of self-management training in the 2 diabetes. A systematic review of randomized controlled trials: Diabetes Care, 2001; 24; 561-87, pmid: 11289485

12. Smaldone A, Ganda OP, McMurrich S, Should group education classes be separated by type of diabetes?: Diabetes Care, 2006; 29; 1656-58, pmid: 16801595

13. Adolfsson ET, Walker-Engstrom M, Smide B, Wikblad K, Patient education in type 2 diabetes-a randomized controlled 1-year follow-up study: Diabetes Res Clin Pract, 2007; 76; 341-50, pmid: 17069923

14. Tessier DM, Lassmann-Vague VJR, Diabetes and education in the elderly: Diabetes and Metabolism, 2007; 33; S75-78, pmid: 17702101

15. Amano Y, Sugiyanna M, Lee JS, Glycemic index-based nutritional education improves blood glucose control in Japanese adults: Diabetes Care, 2007; 30; 1874-76, pmid: 17440171

16. Dunbar-Jacob J, Models for changing patient behavior. Creating successful self-care plans: American Journal of Nursing, 2007; 107; 20-25, pmid: 17563429

17. http://www.diabeteseducator.org/DiabetesEducation/Definitions.html

18. Boulos MN, Harvey FE, Roudsari AV, A proposed semantic framework for diabetes education content management, customization and delivery within the M2DM project: Comput Methods Programs Biomed, 2006; 83; 188-97, pmid: 16934361

19. Keers JC, Groen H, Sluiter WJ, Cost and benefits of a multidisciplinary intensive diabetes education programme: J Eval Clin Pract, 2005; 11; 293-300, pmid: 15869559

20. Brown JB, Pedula KL, Baskt AW, The progressive cost of complications in type 2 diabetes mellitus: Arch Internal Medicine, 1999; 159; 1873-80

21. Wagner EH, Sandhu N, Newton KM, Effect of improved glycemic control on health care costs and utilization: JAMA, 2001; 285; 1963-64, pmid: 11308429

22. Han J, Lin H, Huang W, Modulating gut microbiota as an anti-diabetic mechanism of Berberine: Med Sci Monit, 2011; 17(7); 164-67

23. Onuigbo M, Skalski J, Newly symptomatic central diabetes insipidus in ESRD with adult polycystic kidney disease following intracranial hemorrhage: The first reported case: Med Sci Monit, 2010; 16(3); CS29-32, pmid: 20190689

24. Bissinger A, Grycewic T, Grabowicz W, Endothelial function and left ventricular remodeling in diabetic and non-diabetic patients after acute coronary syndrome: Medical Science Monitor, 2011; 17(2); CR73-77, pmid: 21278691

25. Zhou J, Yang J, Zhao L, Variants in KCNQ1, AP3S1, MAN2A1, and ALDH7A1 and the risk of the 2 diabetes in the Chinese Northern Han population: A case-control study and meta-analysis: Med Sci Monit, 2010; 16(6); BR179-83, pmid: 20512086

26. Golbidi S, Laher I, Antioxidant therapy in human endocrine disorders: Med Sci Monit, 2010; 16(1); RA9-24, pmid: 20037503

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750